Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Kenakin

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Drug Discovery Today. Technologies|September 21, 2013
Analytical pharmacology and allosterism: the importance of quantifying drug parameters in drug discoveryTerry Kenakin
Current Neuropharmacology|March 24, 2009
Allosteric theory: taking therapeutic advantage of the malleable nature of GPCRsTerry Kenakin
Science'S STKE : Signal Transduction Knowledge Environment|July 5, 2006
Receptors as microprocessors: pharmacological nuance on metabotropic glutamate receptors 1alphaTerry Kenakin
Proceedings of the Western Pharmacology Society|July 9, 2008
How pharmacological receptor theory can guide new drug discovery CCR5 HIV inhibitors in AIDS as a case studyTerry Kenakin
ACS Chemical Biology|February 6, 2009
Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effectTerry Kenakin
Nature Reviews. Drug Discovery|June 18, 2024
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attritionTerry Kenakin
Chemical Reviews|February 10, 2016
Theoretical Aspects of GPCR-Ligand Complex PharmacologyTerry Kenakin
Trends in Pharmacological Sciences|October 21, 2015
New Lives for Seven Transmembrane Receptors as Drug TargetsTerry Kenakin
Trends in Pharmacological Sciences|July 22, 2014
What is pharmacological 'affinity'? Relevance to biased agonism and antagonismTerry Kenakin
Methods in Molecular Biology (Clifton, N.J.)|August 12, 2015
The Measurement of Receptor Signaling BiasTerry Kenakin
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Drug Discovery Today. Technologies|September 21, 2013
Analytical pharmacology and allosterism: the importance of quantifying drug parameters in drug discoveryTerry Kenakin
Current Neuropharmacology|March 24, 2009
Allosteric theory: taking therapeutic advantage of the malleable nature of GPCRsTerry Kenakin
Science'S STKE : Signal Transduction Knowledge Environment|July 5, 2006
Receptors as microprocessors: pharmacological nuance on metabotropic glutamate receptors 1alphaTerry Kenakin
Proceedings of the Western Pharmacology Society|July 9, 2008
How pharmacological receptor theory can guide new drug discovery CCR5 HIV inhibitors in AIDS as a case studyTerry Kenakin
ACS Chemical Biology|February 6, 2009
Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effectTerry Kenakin
Nature Reviews. Drug Discovery|June 18, 2024
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attritionTerry Kenakin
Chemical Reviews|February 10, 2016
Theoretical Aspects of GPCR-Ligand Complex PharmacologyTerry Kenakin
Trends in Pharmacological Sciences|October 21, 2015
New Lives for Seven Transmembrane Receptors as Drug TargetsTerry Kenakin
Trends in Pharmacological Sciences|July 22, 2014
What is pharmacological 'affinity'? Relevance to biased agonism and antagonismTerry Kenakin
Methods in Molecular Biology (Clifton, N.J.)|August 12, 2015
The Measurement of Receptor Signaling BiasTerry Kenakin
Pageof 12